share_log

康方生物:董事會會議召開日期

AKESO: DATE OF BOARD MEETING

HKEX ·  Mar 6 17:53

Summary by Futu AI

康方生物科技(開曼)有限公司(「康方生物」)將於2024年3月18日(星期一)召開董事會會議,主要目的是考慮及批准截至2023年12月31日止年度的年度業績報告及其發佈。會議將由主席兼執行董事夏瑜博士主持,並將處理其他事項。董事會成員還包括執行董事李百勇博士、王忠民博士及夏羽先生,非執行董事周伊博士及謝榕剛先生,以及獨立非執行董事曾駿文博士、徐岩博士及TAN Bo先生。
康方生物科技(開曼)有限公司(「康方生物」)將於2024年3月18日(星期一)召開董事會會議,主要目的是考慮及批准截至2023年12月31日止年度的年度業績報告及其發佈。會議將由主席兼執行董事夏瑜博士主持,並將處理其他事項。董事會成員還包括執行董事李百勇博士、王忠民博士及夏羽先生,非執行董事周伊博士及謝榕剛先生,以及獨立非執行董事曾駿文博士、徐岩博士及TAN Bo先生。
Kangfang Biotechnology (Cayman) Co., Ltd. (“Kangfang Biotech”) will hold a Board meeting on Monday, 18 March 2024. The primary purpose of which is to consider and approve the annual results report for the year ended 31 December 2023 and its publication. The meeting will be chaired by Dr. Xia Yu, Chairman and Executive Director, and will address other matters. The Board members also include Executive Directors Dr. Li Baeyung, Dr. Wang Zhongmin and Mr. Xia Yue, Non-Executive Directors Dr. Zhou Yi and Mr. Xie Banyang-gang, and Independent Non-Executive Directors Dr. Zeng Junwen, Dr. Xu Yan and Mr. Tan Bo.
Kangfang Biotechnology (Cayman) Co., Ltd. (“Kangfang Biotech”) will hold a Board meeting on Monday, 18 March 2024. The primary purpose of which is to consider and approve the annual results report for the year ended 31 December 2023 and its publication. The meeting will be chaired by Dr. Xia Yu, Chairman and Executive Director, and will address other matters. The Board members also include Executive Directors Dr. Li Baeyung, Dr. Wang Zhongmin and Mr. Xia Yue, Non-Executive Directors Dr. Zhou Yi and Mr. Xie Banyang-gang, and Independent Non-Executive Directors Dr. Zeng Junwen, Dr. Xu Yan and Mr. Tan Bo.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.